Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma

被引:198
作者
Shattuck, TM
Westra, WH
Ladenson, PW
Arnold, A
机构
[1] Univ Connecticut, Sch Med, Ctr Mol Med, Farmington, CT 06030 USA
[2] Univ Connecticut, Sch Med, Div Endocrinol & Metab, Farmington, CT 06030 USA
[3] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD USA
关键词
D O I
10.1056/NEJMoa044190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Papillary thyroid carcinoma is frequently multifocal. We investigated whether noncontiguous tumor foci arise from intraglandular metastases from a single primary tumor or originate as unrelated clones derived from independent precursors. METHODS: Using a polymerase-chain-reaction assay involving the human androgen receptor gene (HUMARA), we analyzed the patterns of X-chromosome inactivation of multiple distinct foci of well-differentiated multifocal papillary thyroid cancer from 17 women. RESULTS: Multiple thyroid tumor foci from 10 of 17 patients yielded DNA of adequate quality and were heterozygous for the HUMARA polymorphism and hence suitable for analysis. A single X chromosome was inactivated in each focus, consistent with its monoclonality. When the specific monoclonal configurations of each patient's discrete tumor foci were compared, discordant patterns indicative of independent origins were observed among the tumors from five patients; results in the remaining five were consistent with either a shared or independent clonal origin. CONCLUSIONS: Individual tumor foci in patients with multifocal papillary thyroid cancer often arise as independent tumors.
引用
收藏
页码:2406 / 2412
页数:7
相关论文
共 45 条
[1]   MONOCLONALITY AND ABNORMAL PARATHYROID-HORMONE GENES IN PARATHYROID ADENOMAS [J].
ARNOLD, A ;
STAUNTON, CE ;
KIM, HG ;
GAZ, RD ;
KRONENBERG, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (11) :658-662
[2]   MONOCLONALITY OF PARATHYROID TUMORS IN CHRONIC-RENAL-FAILURE AND IN PRIMARY PARATHYROID HYPERPLASIA [J].
ARNOLD, A ;
BROWN, MF ;
URENA, P ;
GAZ, RD ;
SARFATI, E ;
DRUEKE, TB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2047-2053
[3]  
BONGARZONE I, 1994, CANCER RES, V54, P2979
[4]  
Carcangiu M L, 1985, Pathol Annu, V20 Pt 1, P1
[5]   BRAF mutation in papillary thyroid carcinoma [J].
Cohen, J ;
Xing, MZ ;
Mambo, E ;
Guo, ZM ;
Wu, GG ;
Trink, B ;
Beller, U ;
Westra, WH ;
Ladenson, PW ;
Sidransky, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) :625-627
[6]   Editorial:: Challenging dogma in thyroid cancer molecular genetics -: Role of RET/PTC and BRAF in tumor initiation [J].
Fagin, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4264-4266
[7]  
Fey MF, 1996, ANN ONCOL, V7, P121
[8]   A GENOMIC SEQUENCING PROTOCOL THAT YIELDS A POSITIVE DISPLAY OF 5-METHYLCYTOSINE RESIDUES IN INDIVIDUAL DNA STRANDS [J].
FROMMER, M ;
MCDONALD, LE ;
MILLAR, DS ;
COLLIS, CM ;
WATT, F ;
GRIGG, GW ;
MOLLOY, PL ;
PAUL, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1827-1831
[9]   BRAF mutations in papillary carcinomas of the thyroid [J].
Fukushima, T ;
Suzuki, S ;
Mashiko, M ;
Ohtake, T ;
Endo, Y ;
Takebayashi, Y ;
Sekikawa, K ;
Hagiwara, K ;
Takenoshita, S .
ONCOGENE, 2003, 22 (41) :6455-6457
[10]  
Grebe S K, 1997, Cancer Treat Res, V89, P91